Skip to content
Medical Health Aged Care

Kao Corporation: Regarding the Nomination of Director Candidates for Our Company

Kao Corporation < 1 mins read
TOKYO--BUSINESS WIRE--

Kao's Board of Directors and management team strive to increase shareholder value from a long-term perspective based on our business strategy. For the purpose of enhancing our corporate value, we are committed to engaging directly and constructively with all our stakeholders and welcome new perspectives to address challenges.

Kao adheres to a robust selection process to ensure an optimal composition of the Board of Directors. As announced in the December 12 press release, this fiscal year, the selection of candidates was deliberated over a period of more than six months by the Board of Directors and the Committee for Examination of Nominees for Directors and Audit & Supervisory Board Members. The candidates for Directors and Audit & Supervisory Board Members were announced on December 2 to coincide with the announcement of the new Executive Officer structure.

The announced individuals are proposed candidates and do not preclude proposals from other shareholders. Following our company's selection process, we are currently conducting the appropriate evaluation for the director candidates proposed by certain shareholders.

Kao will remain committed to ensuring fair disclosure of information to all stakeholders.


Contact details:

Media inquiries should be directed to:
Public Relations
Kao Corporation
corporate_pr@kao.com

Media

More from this category

  • General News, Medical Health Aged Care
  • 19/12/2024
  • 11:36
Chapter One Advisors

LGP Welcomes Transformative Changes to Medicinal Cannabis Access in WA

Little Green Pharma Ltd (ASX: LGP)(“LGP” or “the Company”) welcomes the significant regulatory changes introduced in Western Australia for the prescribing and dispensing of…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 19/12/2024
  • 11:34
JMM

BlinkLab Achieves Pivotal Step Towards FDA Approval for Autism Diagnostic App

Positive Outcome from FDA Pre-Submission Meeting Highlights ● Positive outcome received from a Pre-Submission meeting with the U.S. Food and Drug Administration (“FDA”) regarding the regulatory pathway for BlinkLab Dx 1 diagnostic app. ● The FDA has confirmed the design for the BlinkLab Dx 1 registrational program, which will consist of an Initial Study Phase that then transitions into the Main Study. The Initial Phase will recruit up to 100 children with the main registrational study up to 1,000 subjects recruited from up to ten clinical sites. ● Several leading clinical sites across the U.S. have already been selected with…

  • Contains:
  • Emergency Services, Medical Health Aged Care
  • 19/12/2024
  • 11:01
Black Dog Institute

Black Dog Institute welcomes continued investment in mental health support for healthcare workers

December 2024: Black Dog Institute welcomes and commends the Federal Government’s continued commitment to improving mental health outcomes for vulnerable groups through today’s funding announcements in the Mid-Year Economic and Fiscal Outlook (MYEFO). This funding will enable the continuation of key programs that provide vital mental health support to some of our nation's most critical workforces. Healthcare professionals are the backbone of our nation’s health system and play an essential role in providing our communities with the tools, services, and support they need to live healthier lives, both mentally and physically. In the years following COVID-19, frontline workers have continued…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.